Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.
Alcohol use disorders
Co-occurring disorders
Health belief model
Medication-assisted treatment
Medications for addiction treatment
Severe mental illness
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
19
09
2019
revised:
09
03
2020
accepted:
08
04
2020
entrez:
13
6
2020
pubmed:
13
6
2020
medline:
29
7
2021
Statut:
ppublish
Résumé
Medications for alcohol use disorder (MAUD) are underutilized in mental health settings. Increasing use of MAUD requires increasing both the availability of these medications and the demand by individuals who could benefit. Few studies have explored the views of individuals with severe mental illness and alcohol use disorder about MAUD. We sought to examine, among individuals treated in publicly funded community mental health clinics, perceived need for and attitudes toward MAUD. We conducted 8 focus groups with 87 participants treated in public mental health clinics in Los Angeles County. We aimed to include individuals with a current or past AUD diagnosis and individuals helping others (e.g., a family member) who drink. We examined responses using domains associated with the Health Belief Model to identify factors that shape acceptance of MAUD. Participants were 53% female; most were minorities. Average age was 47 years (SD = 11). Twenty-four reported never drinking, 13 of whom had a current or past diagnosis of AUD. Twenty-two reported drinking 4 or more times per week. Three-quarters had not heard of naltrexone. Participants understood that alcohol use has severe adverse consequences and perceived themselves to be highly susceptible to these consequences. Regarding attitudes toward MAUD, participants described an internal locus of control (e.g., their own desires, actions, and effort) as central to addressing problem drinking; this shaped their views that MAUD would have only modest benefits and potentially high burden. Those individuals who had tried MAUD expressed the most optimism about its effectiveness. Participants worried MAUD would impede the development of self-control over drinking by fostering dependence on medication and undermining self-discipline. Client education and counseling that emphasizes MAUD as a tool to build clients' self-control may increase demand for these medications in mental health settings.
Sections du résumé
BACKGROUND
Medications for alcohol use disorder (MAUD) are underutilized in mental health settings. Increasing use of MAUD requires increasing both the availability of these medications and the demand by individuals who could benefit. Few studies have explored the views of individuals with severe mental illness and alcohol use disorder about MAUD. We sought to examine, among individuals treated in publicly funded community mental health clinics, perceived need for and attitudes toward MAUD.
METHODS
We conducted 8 focus groups with 87 participants treated in public mental health clinics in Los Angeles County. We aimed to include individuals with a current or past AUD diagnosis and individuals helping others (e.g., a family member) who drink. We examined responses using domains associated with the Health Belief Model to identify factors that shape acceptance of MAUD.
RESULTS
Participants were 53% female; most were minorities. Average age was 47 years (SD = 11). Twenty-four reported never drinking, 13 of whom had a current or past diagnosis of AUD. Twenty-two reported drinking 4 or more times per week. Three-quarters had not heard of naltrexone. Participants understood that alcohol use has severe adverse consequences and perceived themselves to be highly susceptible to these consequences. Regarding attitudes toward MAUD, participants described an internal locus of control (e.g., their own desires, actions, and effort) as central to addressing problem drinking; this shaped their views that MAUD would have only modest benefits and potentially high burden. Those individuals who had tried MAUD expressed the most optimism about its effectiveness.
CONCLUSIONS
Participants worried MAUD would impede the development of self-control over drinking by fostering dependence on medication and undermining self-discipline. Client education and counseling that emphasizes MAUD as a tool to build clients' self-control may increase demand for these medications in mental health settings.
Identifiants
pubmed: 32527506
pii: S0740-5472(19)30517-3
doi: 10.1016/j.jsat.2020.108007
pmc: PMC7306264
mid: NIHMS1588606
pii:
doi:
Substances chimiques
Naltrexone
5S6W795CQM
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108007Subventions
Organisme : NIAAA NIH HHS
ID : R34 AA025480
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Int J Ment Health Nurs. 2003 Jun;12(2):110-8
pubmed: 12956022
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Br J Addict. 1992 May;87(5):743-54
pubmed: 1591525
J Subst Abuse Treat. 2016 Feb;61:47-59
pubmed: 26531892
J Psychosom Res. 1999 Dec;47(6):555-67
pubmed: 10661603
Am J Addict. 2003 Jul-Sep;12(4):281-94
pubmed: 14504021
Drug Alcohol Depend. 2013 Jan 1;127(1-3):59-64
pubmed: 22770461
Health Educ Q. 1984 Spring;11(1):1-47
pubmed: 6392204
Am J Psychiatry. 2018 Jul 1;175(7):665-673
pubmed: 29961358
Asian Pac J Cancer Prev. 2016;17(4):2229-33
pubmed: 27221923
J Addict Med. 2017 Jan/Feb;11(1):1-2
pubmed: 27898497
J Subst Abuse Treat. 2013 Sep;45(3):287-92
pubmed: 23566446
Drug Alcohol Depend. 2009 Jan 1;99(1-3):345-9
pubmed: 18819759
Acta Psychiatr Scand. 2000 Feb;101(2):119-24
pubmed: 10706011
Health Educ Res. 2005 Jun;20(3):275-90
pubmed: 15632099
Am J Drug Alcohol Abuse. 2011 Mar;37(2):105-10
pubmed: 21219256
Drug Alcohol Depend. 2016 Mar 1;160:112-8
pubmed: 26796596
Br J Clin Psychol. 1996 Sep;35(3):393-7
pubmed: 8889080
Int J Law Psychiatry. 1989;12(2-3):133-48
pubmed: 2599747
Psychiatr Serv. 2004 Mar;55(3):221
pubmed: 15001719
BMC Psychiatry. 2010 Jan 27;10:9
pubmed: 20105311
J Subst Abuse Treat. 2009 Jul;37(1):95-100
pubmed: 19004598
Alcohol Health Res World. 1994;18(3):220-227
pubmed: 31798131
Psychol Serv. 2009 Feb 1;6(1):74-84
pubmed: 20401336
J Gen Intern Med. 2018 Mar;33(3):258-267
pubmed: 29086341
Acta Psychiatr Scand. 1988 Jul;78(1):18-23
pubmed: 3176993
J Consult Clin Psychol. 1978 Dec;46(6):1192-1211
pubmed: 153349
Am J Drug Alcohol Abuse. 2000 Aug;26(3):443-60
pubmed: 10976668
Subst Use Misuse. 2014 May;49(6):762-9
pubmed: 24601784
J Subst Abuse Treat. 2015 Dec;59:99-103
pubmed: 26254317
Am Psychol. 1991 Oct;46(10):1036-45
pubmed: 1746771
Ann Behav Med. 2005 Jun;29(3):181-91
pubmed: 15946112
Psychiatr Serv. 2017 Dec 1;68(12):1232-1238
pubmed: 28712356
Eur Neuropsychopharmacol. 2001 Oct;11 Suppl 4:S391-6
pubmed: 11587886
J Subst Abuse Treat. 2015 Oct;57:89-95
pubmed: 25986647
Eur Addict Res. 2002 Apr;8(2):84-93
pubmed: 11979011
J Subst Abuse Treat. 2013 Sep;45(3):302-5
pubmed: 23786852
Soc Sci Med. 2012 Jan;74(1):92-100
pubmed: 22133584
J Psychiatr Pract. 2009 Jan;15(1):34-44
pubmed: 19182563
J Subst Abuse Treat. 2008 Jan;34(1):25-35
pubmed: 17574798
Patient Prefer Adherence. 2010 Oct 05;4:369-77
pubmed: 21049089
Eur Addict Res. 2011;17(1):44-54
pubmed: 20975276
Health Commun. 2015;30(6):566-76
pubmed: 25010519
Health Commun. 2016;31(6):707-17
pubmed: 26529605
Health Educ Monogr. 1978 Spring;6(2):160-70
pubmed: 689890
Int J Drug Policy. 2016 Feb;28:1-9
pubmed: 26790691
Ind Health. 2011;49(3):365-73
pubmed: 21372436
Addict Behav. 2006 Jul;31(7):1101-15
pubmed: 16139436
J Clin Psychopharmacol. 2006 Dec;26 Suppl 1:S13-9
pubmed: 17114950
Addict Behav. 2003 Oct;28(8):1497-505
pubmed: 14512073
Health Aff (Millwood). 2017 Oct 1;36(10):1739-1747
pubmed: 28971918
Schizophr Res. 2000 Jan 21;41(2):349-55
pubmed: 10708344
Eur Addict Res. 2010;16(1):53-60
pubmed: 20016186
Psychol Serv. 2013 Nov;10(4):410-419
pubmed: 23356858
J Behav Health Serv Res. 2015 Oct;42(4):417-36
pubmed: 24595815
J Subst Abuse Treat. 2017 Jun;77:38-43
pubmed: 28476269